Clearstead Advisors LLC increased its stake in Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY – Free Report) by 197.6% during the third quarter, HoldingsChannel.com reports. The fund owned 4,518 shares of the biopharmaceutical company’s stock after buying an additional 3,000 shares during the period. Clearstead Advisors LLC’s holdings in Alnylam Pharmaceuticals were worth $800,000 at the end of […]